Related Experiment Video
Updated: Jul 20, 2026
12:44
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
Chondrocyte genomics: implications for disease modification in osteoarthritis
K Wayne Marshall1, Hongwei Zhang, Nadine Nossova
1ChondroGene, 800 Petrolia Road, Unit 15, Toronto, Ontario, Canada. wmarshall@chondrogene.com
Drug Discovery Today
|August 29, 2006
Summary
Genomic technologies offer new insights into osteoarthritis (OA) at the molecular level. Research using functional genomics and systems biology aims to identify diagnostic and therapeutic targets for better OA management.
Area of Science:
- Genomics
- Molecular Biology
- Systems Biology
Background:
- Genomic technologies, including genome-wide association and gene-expression studies, are advancing rapidly.
- Osteoarthritis (OA) research is increasingly leveraging these genomic tools.
- Understanding OA at a molecular level presents both technical and analytical challenges.
Purpose of the Study:
- To explore the application of genomic technologies in osteoarthritis research.
- To identify genes involved in chondrocyte response to cartilage injury and repair.
- To clarify the role of chondrocytes in OA onset, progression, and outcomes.
Main Methods:
- Utilizing functional genomics to analyze gene expression and cellular responses.
- Employing systems biology approaches to model OA as a multifactorial disease.
- Integrating data from articular cartilage, synovium, synovial fluid, subchondral bone, and peripheral blood.
Main Results:
- Genomic studies are expected to reveal key genes in chondrocyte function and OA pathogenesis.
- Systems biology will provide a comprehensive molecular portrait of OA.
- Identification of novel molecular pathways implicated in OA development and progression.
Conclusions:
- Advances in genomic technologies are crucial for a deeper molecular understanding of osteoarthritis.
- Functional genomics and systems biology will identify novel diagnostic and therapeutic targets.
- This integrated approach promises improved disease management strategies for osteoarthritis.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...